Concord Medical Services Stock Today

CCM Stock  USD 4.77  0.08  1.65%   

Performance

Weak

 
Weak
 
Strong

Odds Of Distress

Above Average

 
High
 
Low
Concord Medical is selling at 4.77 as of the 16th of February 2025; that is 1.65 percent down since the beginning of the trading day. The stock's lowest day price was 4.77. Concord Medical has more than 60 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 18th of November 2024 and ending today, the 16th of February 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
11th of December 2009
Category
Healthcare
Classification
Health Care
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the Peoples Republic of China. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the Peoples Republic of China. The company has 2.82 M outstanding shares of which 4.79 K shares are currently shorted by investors with about 0.26 days to cover. More on Concord Medical Services

Concord Stock Highlights

ESG Sustainability
Environmental
Governance
Social
ChairmanJianyu Yang
Thematic IdeaHealthcare (View all Themes)
Old NameCan Tho Mineral and Cement JSC
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, Karachi All Share, Healthcare, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.120.1
Fairly Up
Slightly volatile
Total Current Liabilities2.4 B2.2 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total2.8 B2.7 B
Sufficiently Up
Slightly volatile
Total AssetsBB
Way Down
Slightly volatile
Total Current Assets736.9 M555.5 M
Significantly Up
Slightly volatile
Debt Levels
Concord Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Concord Medical's financial leverage. It provides some insight into what part of Concord Medical's total assets is financed by creditors.
Liquidity
Concord Medical Services has 3.3 B in debt with debt to equity (D/E) ratio of 1.25, which is OK given its current industry classification. Concord Medical Services has a current ratio of 0.7, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Concord to invest in growth at high rates of return.

Change To Inventory

53.72 Million
Concord Medical Services (CCM) is traded on New York Stock Exchange in USA. It is located in East Zone, Hanwei Plaza, Beijing, China, 100020 and employs 727 people. Concord Medical is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 20.71 M. Concord Medical Services runs under Health Care Providers & Services sector within Health Care industry. The entity has 2.82 M outstanding shares of which 4.79 K shares are currently shorted by investors with about 0.26 days to cover. Concord Medical Services has about 157.39 M in cash with (276.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72.
Check Concord Medical Probability Of Bankruptcy
Ownership Allocation
The market capitalization of Concord Medical Services is $20.71 Million. Concord Medical Services shows 17.99 percent of its outstanding shares held by insiders and 0.11 percent owned by other corporate entities. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Concord Ownership Details

Concord Stock Institutional Holders

InstituionRecorded OnShares
Rhumbline Advisers2024-12-31
2.5 K
Ubs Group Ag2024-09-30
923
View Concord Medical Diagnostics

Concord Medical Historical Income Statement

At this time, Concord Medical's Interest Expense is very stable compared to the past year. As of the 16th of February 2025, Cost Of Revenue is likely to grow to about 741.4 M, while Total Revenue is likely to drop about 458 M. View More Fundamentals

Concord Stock Against Markets

Concord Medical Corporate Management

Xun LiuFinancial ControllerProfile
Qing PanDirectorProfile
Matthew CallisterChief Medical OfficerProfile
Boxun ZhangIndependent DirectorProfile
When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.86)
Revenue Per Share
107.978
Quarterly Revenue Growth
(0.23)
Return On Assets
(0.04)
Return On Equity
(0.32)
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.